home / stock / bttx / bttx news

BTTX News and Press, Better Therapeutics Inc. From 03/05/24

Stock Information
Company Name: Better Therapeutics Inc.
Stock Symbol: BTTX
Market: NASDAQ
Website: bettertx.com
Menu
BTTX BTTX Quote BTTX Short BTTX News BTTX Articles BTTX Message Board
Get BTTX Alerts

News, Short Squeeze, Breakout and More Instantly...
BTTX - Better Therapeutics Announces an Innovative Partnership with the American College of Lifestyle Medicine to Expand Access to AspyreRx Across 1,400 Federally Qualified Health Centers

One million prescriptions for AspyreRx will be offered to patients in underserved communities disproportionately affected by type 2 diabetes Better Therapeutics, Inc. (NASDAQ: BTTX), a pioneer in developing prescription digital therapeutics (PDTs) for treating cardiometabolic diseas...
BTTX - Better Therapeutics Announces Acceptance of Late Breaking Abstract for Its AspyreRx Pivotal Trial 180 Day Outcomes and Participation at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

Company to host sponsored education session on Saturday, March 09, 2024; Expanding access to a high quality and effective lifestyle modification intervention Better Therapeutics, Inc. (NASDAQ: BTTX), a pioneer in developing prescription digital therapeutics (PDTs) for treating cardi...

BTTX - Better Therapeutics and Biotricity Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ORLANDO, FL / ACCESSWIRE / March 1, 2024 / RedChip Companies will air interviews with Better Therapeutics, Inc. (Nasdaq:BTTX) and Biotricity, Inc. (Nasdaq:BTCY) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, March 2, at 7 p.m. Eastern T...

BTTX - Better Therapeutics Receives FDA Breakthrough Device Designation for Digital Therapeutic Platform Targeting Advanced Liver Disease

Signifies the FDA’s recognition of the Company’s novel Cognitive Behavioral Therapy as a potential treatment for metabolic dysfunction-associated steatohepatitis Opens an accelerated path towards a potential second indication Better Therapeutics, Inc. (NASDAQ: ...
BTTX - Better Therapeutics Signs Rebate Agreement with One of the Largest Pharmacy Benefit Managers in the US for its AspyreRx Diabetes Treatment

Agreement is an important step towards securing broad coverage Better Therapeutics Inc. (NASDAQ: BTTX), a pioneer in developing prescription digital therapeutics (PDTs) for treating cardiometabolic diseases, today announced that it has entered into a rebate agreement with one of the...

BTTX - Better Therapeutics and Glooko Announce Partnership to Accelerate Adoption of AspyreRx to Treat Type 2 Diabetes in the United States

Better Therapeutics Inc. (NASDAQ: BTTX), a pioneer in developing prescription digital therapeutics (PDTs) for treating cardiometabolic diseases, and Glooko, Inc. , a global leader in chronic condition management, today announced a partnership to integrate Better Therapeutics’ Aspyr...

BTTX - Better Therapeutics applies for FDA breakthrough designation for NASH device

2024-01-02 10:08:42 ET More on Better Therapeutics Better Therapeutics, Inc. (BTTX) Q3 2023 Earnings Call Transcript Better Therapeutics, Inc. 2023 Q3 - Results - Earnings Call Presentation Better Therapeutics amends debt facility, implements cost-saving measures ...
BTTX - Better Therapeutics Announces Submission for FDA Breakthrough Device Designation for Digital Therapeutic Platform to Treat Liver Disease

Better Therapeutics, Inc. (NASDAQ: BTTX), a pioneer in developing prescription digital therapeutics (PDTs) to treat cardiometabolic diseases, today announced it has submitted a request to the U.S. Food and Drug Administration (FDA) for Breakthrough Device Designation for its novel PDT designed ...

BTTX - Better Therapeutics files to sell 20M shares of common stock for holders

2023-12-13 17:34:11 ET More on Better Therapeutics Better Therapeutics amends debt facility, implements cost-saving measures Seeking Alpha’s Quant Rating on Better Therapeutics Historical earnings data for Better Therapeutics For further details see: ...

BTTX - Better Therapeutics amends debt facility, implements cost-saving measures

2023-11-28 08:49:38 ET More on Better Therapeutics Better Therapeutics, Inc. (BTTX) Q3 2023 Earnings Call Transcript Better Therapeutics, Inc. 2023 Q3 - Results - Earnings Call Presentation Seeking Alpha’s Quant Rating on Better Therapeutics Historical...
Previous 10 Next 10